Drug Profile
Research programme: narcotic dependency therapeutics - Pfizer
Alternative Names: CJ 15208Latest Information Update: 05 Sep 2006
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Opioid kappa receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Substance-related disorders
Most Recent Events
- 05 Sep 2006 Discontinued - Preclinical for Substance-related disorders (unspecified route)
- 08 Apr 2003 Preclinical trials in Substance-related disorders (unspecified route)